JP Morgan Chase
VTYX

JP Morgan Chase’s Ventyx Biosciences VTYX Stock Holding History

JP Morgan Chase’s Portfolio VTYX Stock Details VTYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-7,200
Closed -$241K – 7369
2023
Q1 		$241K Buy
+7,200
New +$280K ﹤0.01% 4954

Other funds holding VTYX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

JP Morgan Chase's VTYX Position: Q1 2026 in Review

JP Morgan Chase sold out of Ventyx Biosciences (VTYX) in Q1 2026, closing a stake of 5,449 shares — an estimated $49.2K sold.

JP Morgan Chase first reported a position in VTYX in Q4 2021 and held it in 17 quarters. The position peaked at $7.83M in Q1 2023. 1 fund tracked by Wall St. Rank holds VTYX as of Q1 2026.

  • JP Morgan Chase reported no remaining Ventyx Biosciences position as of Q1 2026 after selling out during the quarter.
  • JP Morgan Chase sold 5,449 Ventyx Biosciences shares in Q1 2026, an estimated $49.2K.
  • JP Morgan Chase first reported a position in Ventyx Biosciences in Q4 2021 and held it in 17 quarters.
  • JP Morgan Chase's Ventyx Biosciences position peaked at $7.83M in Q1 2023.
  • 1 fund tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.